Targeting EGFR Enriches Stem Cell-Like Properties in Salivary Adenoid Cystic Carcinoma by Activating the Notch1 Pathway.
Yang WangYong HanShengming XuLing ZhangXiangkai ZhangJiong DengWeimin YeShuli LiuPublished in: Cancer management and research (2020)
Our results provide an explanation for the worsened survival observed in some studies of erlotinib therapy in SACC and provide potential therapeutic strategies by combined blockade of the EGFR and Notch1 pathways.